Global Cord Blood - M&A Summary and Business Overview

Life ScienceCompany

Global Cord Blood M&A Summary

Global Cord Blood has acquired 2 companies, including 2 in the last 5 years.

Global Cord Blood’s largest acquisition to date was in 2022, when it acquired Cellenkos for $664M. Global Cord Blood has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include healthcare services (50%) and life science (50%).

Global Cord Blood Business Overview

Where is Global Cord Blood headquartered?

Global Cord Blood is headquartered in Hong Kong, China.

What is Global Cord Blood’s revenue?

Global Cord Blood disclosed revenue of 1,243M CNY for 2022 and 1,160M CNY for 2021.

How many employees does Global Cord Blood have?

Global Cord Blood has 1,202 employees.

What sector is Global Cord Blood in?

Global Cord Blood is a life science company.

When was Global Cord Blood founded?

Global Cord Blood was founded in 2006.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • Total Sectors Invested 2
  • Total Countries Invested 2

Global Cord Blood

Global Cord Blood Corp.

Bank of China Tower 48th Floor 1 Garden Road Central,
Hong Kong,
China,
+852 3605 8180
www.globalcordbloodcorp.com

Global Cord Blood is a provider of umbilical cord blood storage and ancillary services. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. Global Cord Blood was founded in 2006 and is based in Hong Kong, China.


M&A Summary

Buy vs Sell

Year ≤ '17 '18 '19 '20 '21 '22 T
Buy (0.4/yr) # - - 1 - - 1 2
vol $664M $664M
Sell (0.0/yr) # - - - - - - 0
  2

Most Recent M&A

Company Date Value Type
Cellenkos, Inc. 2022-04-29 664M USD Add-on Acquisition
Houston, Texas · www.cellenkosinc.com
Cordlife Group Ltd. 2019-06-04 - Add-on Acquisition
Singapore, Singapore · www.cordlife.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Healthcare Services 1 (50%) - - -
Life Science 1 (50%) 664M (100%) - -
Total 2 $664M - -

By Geo

State/Country Buy Value Sell Value
Singapore 1 - - -
United States 1 664M - -
  Texas 1 664M - -
Domestic - - - -
Cross-border 2 (100%) 664M (100%) - -
Total 2 $664M - -

Deal Values

buy # Total
$100M to $1B 1 $664M
TOTAL $664M
Largest Cellenkos, Inc.
$664M (2022-04-29)

 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Global Cord Blood

Life Science Companies , China Companies